Search for: "Novartis Pharmaceuticals Inc"
Results 81 - 100
of 393
Sorted by Relevance
|
Sort by Date
17 Jun 2010, 6:47 am
Abbott Laboratories, Inc. [read post]
26 Feb 2010, 4:17 pm
Novartis Pharmaceuticals Corp.; Simonian v. [read post]
21 May 2012, 9:33 pm
Mylan Pharmaceuticals Inc. 1:12-cv-00523; filed April 26, 2012 in the District Court of Delaware Infringement of U.S. [read post]
20 Aug 2021, 12:15 pm
In April 2013 a so-called “Dear Doctor” letter was sent out in Canada by Novartis Pharmaceuticals Canada Inc. warning about some serious side effects associated with Tasigna and a drug label change with new information concerning those leukemia drug Tasigna side effects. [read post]
4 Aug 2008, 4:39 am
KV's motion relied on Q-Pharma, Inc. [read post]
22 Jul 2008, 10:42 am
Novartis Pharmaceuticals Corp., 2008 WL 2683047 (E.D. [read post]
16 Oct 2006, 7:58 pm
Novartis sued Par Pharmaceuticals, the third and most recent company to file an ANDA for generic Lotrel. [read post]
24 Jul 2011, 1:21 pm
Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
5 Aug 2016, 2:10 pm
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention (Posted by Tom Lamb at DrugInjuryWatch.com) This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors… [read post]
25 Feb 2012, 10:04 am
Novartis Pharm. [read post]
15 May 2017, 2:32 am
Novartis / Supreme CourtEP Law updates us on a recent case in the Supreme Court of the Netherlands - Sun Pharmaceutical Industries (Europe) B.V. v. [read post]
30 Jun 2014, 4:23 am
Johnson & Johnson Medtronic Merck Millennium Pharmaceuticals, Inc. [read post]
19 Oct 2012, 6:13 pm
The majority of the assets in these 18 markets would be divested to Par Pharmaceutical, Inc. [read post]
12 Jun 2011, 9:17 pm
.; Par Pharmaceutical Inc. [read post]
20 Jul 2009, 2:00 pm
FDA And Health Canada Had Zelnorm Removed From Respective Markets In March 2007 Due To Concerns About Cardiovascular Safety (Posted by Tom Lamb at DrugInjuryWatch.com) In November 2008 a national class action was filed against Novartis Pharmaceuticals Canada Inc., seeking damages on behalf of all Canadians who ingested the medication Zelnorm (tegaserod) which was used by patients who had severe constipation or irritable… [read post]
11 Dec 2009, 11:13 am
This December 2009 FDA MedWatch alert also provided links to: (1) "Prescribing Information" -- also known as the package insert or label -- for Voltaren Gel; and, (2) a "Dear Healthcare Professional Letter" -- commonly called a "Dear Doctor" letter -- from Endo Pharmaceuticals Inc. and Novartis Consumer Health, Inc., the companies responsible for Voltaren Gel in the U.S. [read post]
30 Aug 2016, 6:49 am
" Novartis Pharmaceuticals Corporation et al v. [read post]
11 Dec 2017, 7:39 am
Novartis Pharmaceuticals Corporation, 4-17-cv-04405 (CAND December 7, 2017, Order) (Gilliam, USDJ) [read post]
25 Oct 2010, 11:10 am
Coming forward to the present time, on October 14, 2010 Health Canada issued a MedEffect e-Notice, "ACLASTA (zoledronic acid 5mg/100mL) solution for intravenous infusion - Association with renal dysfunction - Novartis Pharmaceuticals Canada Inc. [read post]
30 Dec 2012, 3:30 am
("Indchemie"), and Torrent Pharmaceuticals Ltd. and Torrent Pharma Inc. [read post]
